News

Published on 25 Nov 2021 on Simply Wall St. via Yahoo Finance

Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) insider upped their holding by 67% earlier this year


Article preview image

Viewing insider transactions for Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN ) over the last year, we see that insiders were net buyers. This means that a larger number of shares were purchased by insiders in relation to shares sold.

While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.

See our latest analysis for Cyclerion Therapeutics

NASDAQ.CYCN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
12 Best Biotech Penny Stocks to Invest In

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip ou...

Insider Monkey via Yahoo Finance 24 Mar 2024

Cyclerion Therapeutics' Market Cap Drops To US$5.0m Leaving Insiders With Losses

Insiders who bought US$1.95m worth of Cyclerion Therapeutics, Inc.'s (NASDAQ:CYCN) stock at an av...

Simply Wall St. via Yahoo Finance 29 Nov 2023

The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion...

Peter Hecht, the co-founder and CEO of embattled biotech Cyclerion Therapeutics Inc. (Nasdaq: CYC...

American City Business Journals 5 Aug 2023

Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company...

Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (form...

Benzinga via Yahoo Finance 12 May 2023

GreenLight Biosciences lays off a quarter of its team

GreenLight Biosciences Holdings Inc. is laying off a quarter of its staff eight months after it w...

American City Business Journals 27 Oct 2022

Cyclerion Therapeutics lays off nearly half of workforce

Cyclerion Therapeutics Inc. is culling its workforce as it narrows its focus to mitochondrial...

American City Business Journals 7 Oct 2022

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.15% By Investing.com

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.15%

Investing.com 6 Oct 2022

Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction

Cyclerion Therapeutics Inc (NASDAQ: CYCN) is reprioritizing development programs and focusing res...

Benzinga via Yahoo Finance 6 Oct 2022

U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.15%

U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.15%

Investing.com 6 Oct 2022

Cyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue Estimates

Cyclerion Therapeutics, Inc. (CYCN) came out with a quarterly loss of $0.31 per share versus the ...

Zacks via Yahoo Finance 10 Aug 2022